Trade Show

Meet Datwyler at
PDA Miniverse

Datwyler at the Forefront of European Parenteral Drug Packaging Innovation

Datwyler engages Europe's pharmaceutical experts in focused technical discussions on container closure integrity, elastomer selection, and the evolving science of sterile injectable packaging.

Date May 21, 2026 – May 22, 2026

Location Croke Park Conference Center | Dublin, Ireland

Details Table # 14

Schedule a Meeting View Event Details

Event Overview

Focused Technical Dialogue for Pharmaceutical Experts

PDA Miniverse brings together a focused community of European pharmaceutical professionals for intensive technical dialogue on combination products, medical devices, and connected health. Datwyler participates to engage quality, manufacturing, and regulatory teams from across the EU on the practical science of container closure integrity, extractables and leachables management, and high-performance elastomer selection for sterile injectable applications. This is the kind of event where real problems get solved — and our team comes prepared with the data, the expertise, and the collaborative mindset to help you find the right path forward.

Attend the collaborative presentation "Enabling Large-Volume Subcutaneous Delivery: A Collaborative Approach Among Suppliers to Accelerate Market Readiness," featuring Paolo Ferrigno alongside experts from Stevanato Group and LTS Device Technologies
Learn how a platform-based development approach leveraging pre-verified compatibility between on-body delivery devices, RTU cartridges, and elastomeric components can streamline development and accelerate time to market
Connect with Datwyler's experts in Dublin to discuss container closure solutions for biologics, prefilled syringe platforms, and parenteral applications

Featured Presentations

Presentation Details

Enabling Large Volume Subcutaneous Delivery: A Collaborative Approach among Suppliers to Accelerating Market Readiness

Date & Time April 15, 2026 • 1:10 PM

Paolo Ferrigno, Product Manager, Prefilled Syringes and Cartridges at Datwyler, joins Valerio Ravazzolo of Stevanato Group and Greg Moakes of LTS Device Technologies to explore how early, structured collaboration among device, primary packaging, and elastomer suppliers can significantly reduce development complexity and accelerate time to market for On-Body Delivery Systems (OBDSs). As subcutaneous biologics grow in volume, viscosity, and therapeutic complexity, OBDSs represent a critical but challenging path to market — and this session presents a platform-based development approach that leverages pre-verified compatibility between on-body delivery devices, ready-to-use cartridges, and elastomeric components. Attendees will gain data-driven insights into break-loose and gliding profiles, dose efficiency, hold-up volume across varying viscosities, and fragmentation and sub-visible particle performance — alongside a structured methodology for test plan design that helps pharmaceutical companies streamline OBDS integration, mitigate component compatibility risks, and support faster commercialization of subcutaneous biologics.

View Paolo Ferrigno View Valerio Ravazzolo View Greg Moakes

Speaker Spotlight

Meet the Speakers

Paolo Ferrigno

Product Manager, Prefilled Syringes & Cartridges | Datwyler

In the industry of primary parenteral packaging since 2017, Paolo Ferrigno is currently the Product Manager for PFS and cartridge components at Datwyler Healthcare. In the same company, Paolo covered different commercial and technical toles before landing back to product management in 2022. Educated in Electronics and later in Marketing, Paolo had in the past a wide range of experiences spanning from R&D for audio/electronics in the automotive and consumer markets to product management for B2B distribution of industrial and electronics components.

View LinkedIn

Valerio Ravazzolo

Product Manager, Cartridge Platform | Stevanato Group

Valerio Ravazzolo is Product Manager for the Cartridge Platform within the DCS Business Unit at Stevanato Group, where he focuses on the evolution of cartridge solutions from both a technical and market perspective.

He joined Stevanato Group in 2015, starting in Quality Assurance and later moving into a Technical Account Manager role. In this position, he supported key customers and gradually expanded his scope of responsibility.

Today, as Product Manager, he brings together this experience to support product strategy, development, and long‑term platform growth.

Valerio holds a master's degree in mechanical engineering from the University of Padua.

View LinkedIn

Greg Moakes

Executive VP, New Business Development | LTS Device Technologies

Greg Moakes is Executive Vice-President of Business Development for LTS Lohmann Device Technologies. Dr Moakes holds a PhD in Chemistry from the Georgia Institute of Technology (Atlanta, GA, US) and an MBA from the Southern Methodist University (Dallas, TX, US). His career had been focused on drug delivery, first specialising in solid-implant dosage formulations and more recently high-volume subcutaneous delivery via on-body delivery systems.

View LinkedIn

Solutions Spotlight

What We're Showcasing at PDA Miniverse

Explore the solutions and technologies most relevant to this event.

Featured Solution

Presentation: Enabling Large-Volume Subcutaneous Delivery — A Collaborative Approach Among Suppliers

Paolo Ferrigno, Product Manager Prefilled Syringes and Cartridges at Datwyler, joins Valerio Ravazzolo of Stevanato Group and Greg Moakes of LTS Device Technologies to present "Enabling Large Volume Subcutaneous Delivery: A Collaborative Approach Among Suppliers to Accelerate Market Readiness" — exploring how cross-supplier partnerships are accelerating the development of platform solutions for large-volume subcutaneous drug delivery.

Featured Solution

First-to-Market 20ml Universal Plunger for Large-Volume Injectables

Datwyler introduces the first-to-market 20ml universal NeoFlex™ plunger, engineered to support the growing demand for large-volume injectable therapies. Designed for compatibility across multiple prefilled syringe and cartridge platforms, this innovation helps simplify development, reduce qualification complexity, and support the next generation of biologic and high-dose therapies.

Featured Solution

Drug Delivery Solutions for Home-Based & Patient-Centric Care

As subcutaneous and at-home administration becomes the new standard, your packaging must keep pace. Datwyler offers reliable components compatible with biologics and GLP-1 formulations, including solutions for auto-injectors, prefillable syringe systems, and ready-to-use components designed for contamination-free fill-finish operations.

Additional Information